FR2034479A1 - - Google Patents

Info

Publication number
FR2034479A1
FR2034479A1 FR7002052A FR7002052A FR2034479A1 FR 2034479 A1 FR2034479 A1 FR 2034479A1 FR 7002052 A FR7002052 A FR 7002052A FR 7002052 A FR7002052 A FR 7002052A FR 2034479 A1 FR2034479 A1 FR 2034479A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7002052A
Other versions
FR2034479B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of FR2034479A1 publication Critical patent/FR2034479A1/fr
Application granted granted Critical
Publication of FR2034479B1 publication Critical patent/FR2034479B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7002052A 1969-01-23 1970-01-21 Expired FR2034479B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB397169 1969-01-23

Publications (2)

Publication Number Publication Date
FR2034479A1 true FR2034479A1 (fr) 1970-12-11
FR2034479B1 FR2034479B1 (fr) 1974-09-27

Family

ID=9768355

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7002052A Expired FR2034479B1 (fr) 1969-01-23 1970-01-21

Country Status (8)

Country Link
US (1) US3660437A (fr)
JP (1) JPS5022032B1 (fr)
CH (1) CH583748A5 (fr)
DE (1) DE2001908A1 (fr)
DK (1) DK127108B (fr)
FR (1) FR2034479B1 (fr)
GB (1) GB1289521A (fr)
NL (1) NL7000484A (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE702023A (fr) * 1966-07-29 1968-01-29

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE702023A (fr) * 1966-07-29 1968-01-29

Also Published As

Publication number Publication date
US3660437A (en) 1972-05-02
GB1289521A (fr) 1972-09-20
FR2034479B1 (fr) 1974-09-27
DE2001908A1 (de) 1970-08-27
NL7000484A (fr) 1970-07-27
CH583748A5 (fr) 1977-01-14
DK127108B (da) 1973-09-24
JPS5022032B1 (fr) 1975-07-28

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU4221168A (fr)
AU450150B2 (fr)
AU442375B2 (fr)
FR2047463A5 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442554B2 (fr)
AU442380B2 (fr)
FR2059570B1 (fr)
AU442538B2 (fr)
AU442535B2 (fr)
AT308690B (fr)
AU442463B2 (fr)
AU470661B1 (fr)
AU1036070A (fr)
AR203167Q (fr)
AU5109569A (fr)
AU5077469A (fr)
AU4949169A (fr)
AU4540468A (fr)
BE737140A (fr)
AU4953367A (fr)
AU5006968A (fr)
AU5066368A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse